|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.095 USD | +3.30% |
|
+3.27% | -33.83% |
| 14/07 | Lineage Cell Therapeutics, Inc. - Special Call | |
| 13/07 | Lineage Cell Therapeutics Provides Update On COR1 Cell Therapy Program For Corneal Endothelial Disease | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.2 | 1.35 | 1.35 |
| Spread/Res. | -11.67% | -21.48% | -21.48% |
| Spread/Supp. | +2.91% | +2.91% | +2.91% |
| Support | 1.03 | 1.03 | 1.03 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
